Study: Antidepressant Paxil might prevent heart failure

Share this article:

The antidepressant Paxil has shown promise in strengthening the heart, new research suggests.

In a discovery that University of Michigan researcher John Tesmer, Ph.D., described as “completely serendipitous,” the drug paroxetine, a.k.a. Paxil, inhibits G protein-coupled receptor kinase 2. That's a protein that becomes over-expressed when people have heart failure.

According to Tesmer, paroxetine improved the strength of the heart's contractions in an animal model, without interfering with the heart rate. Although the drug is not currently prescribed in doses large enough to have a therapeutic effect, further development of the drug's key compounds could yield leads within the next several years, researchers said.

The only caveat: SSRIs, often used to treat depression in nursing home residents, have been associated with an increased risk of falls in the elderly.

The study was published online in ACS Chemical Biology.

Share this article:

More in News

Long-term care continues to lead in deal volume and value: PwC report

Long-term care continues to lead in deal volume ...

Long-term care bucked healthcare industry trends with strong merger and acquisition activity in the second quarter of 2014, according to newly released data from professional services firm PricewaterhouseCoopers.

Empowering nurse practitioners could reduce hospitalizations from SNFs, study finds

Granting more authority to nurse practitioners is associated with reduced hospitalization of skilled nursing facility residents, according to recently published findings.

Pioneer ACO drops out of program, despite reductions in skilled nursing utilization

A California healthcare system has become the latest dropout from the Pioneer Accountable Care Organization program, despite reducing skilled nursing facility utilization and improving its readmission rates. Sharp HealthCare announced its decision in a quarterly financial statement released Tuesday.